Sort
48,018 grants matching “immunotherapy”
Natural killer cells subvert immune checkpoint therapy of tumors
$3,182,665Wayne M. Yokoyama · Washington University · R01 · FY2025 · CA
CHRONIC LYMPHOCYTIC LEUKEMIA RESEARCH CONSORTIUM
$3,179,642University Of California San Diego · P01 · FY2001 · CA
The Immunotherapy of Animal and Human Cancer
$3,172,648Steven A Rosenberg · Clinical Sciences · Z01 · FY2007 · CA
Immunobioogy for Marrow Allografts for Leukemia
$3,166,828Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2013 · CA
DEVELOPMENT AND VALIDATION OF A NOVEL IMMUNOTHERAPY FOR TRAUMATIC HEMORRHAGE
$3,164,353The Geneva Foundation · · FY2020 · Defense Health Agency
A Single Ascending Dose / Multiple Ascending Dose Phase I study of the GSM 776890 in healthy normal subjects
$3,156,733Steven Lee Wagner · University Of California, San Diego · R01 · FY2021 · AG
Baylor College of Medicine Cancer Center
$3,155,163C Kent Osborne · Baylor College Of Medicine · P30 · FY2015 · CA
NOVEL IMMUNE-MODULATING CELLULAR VACCINE FOR PROSTATE CANCER IMMUNOTHERAPY
$3,149,061Duke University · · FY2013 · Department of the Army
Genomics Of Acute Myeloid Leukemia.
$3,144,604Timothy J Ley · Washington University · P01 · FY2021 · CA
Genomics Of Acute Myeloid Leukemia.
$3,144,604Timothy J Ley · Washington University · P01 · FY2023 · CA
INTEGRATED IMMUNOTHERAPY FOR BREAST CANCER
$3,143,805Beckman Research Institute Of The City Of Hope · · FY2012 · Department of the Army
Biomarkers and Mechanisms of Paucibacillary and Latent Tuberculosis
$3,143,754Jerrold J. Ellner · Boston Medical Center · U19 · FY2014 · AI
Genomics Of Acute Myeloid Leukemia.
$3,142,107Timothy J Ley · Washington University · P01 · FY2020 · CA
TCR Gene Modified T Cells for Adoptive Immunotherapy
$3,141,645Michael I Nishimura · Loyola University Chicago · P01 · FY2013 · CA
Cancer Center Support Grant
$3,139,824Steven D Leach · Dartmouth College · P30 · FY2019 · CA
Cancer Center Support Grant
$3,139,824Steven D Leach · Dartmouth College · P30 · FY2018 · CA
Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders
$3,134,725William Childs · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
ADVANCED INTEGRATIVE PLATFORMS FOR CELLULAR IMMUNOTHERAPIES AGAINST RESISTANT HEMATOPOIETIC MALIGNANCIESAND SOLID TUMORS
$3,129,087Yale Univ · · FY2025 · Defense Health Agency
Cancer Center Support Grant
$3,125,750Mark A Israel · Dartmouth College · P30 · FY2011 · CA
Cancer Center Support Grant
$3,125,750Mark A Israel · Dartmouth College · P30 · FY2012 · CA
Maternal Immunization and Determinants of Infant Immunity
$3,121,843Marcela F Pasetti · University Of Maryland Baltimore · U19 · FY2022 · AI
NOVEL TUMOR-TARGETED IMMUNOTHERAPIES AGAINST METASTATIC UVEAL MELANOMA
$3,120,000Thomas Jefferson University · · FY2025 · Defense Health Agency
Enhancing Chimeric Antigen Receptor T Cell Therapies for HematologicMalignancies: Beyond CART 19
$3,119,164Carl H. June · University Of Pennsylvania · P01 · FY2024 · CA
The Immunobiology of Marrow Allografts for Leukemia
$3,117,289Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2010 · CA
Maternal Immunization and Determinants of Infant Immunity
$3,111,452Marcela F Pasetti · University Of Maryland Baltimore · U19 · FY2023 · AI